-
Standardized Whole-Blood Stimulation for Immunometabolism
2026-09-25
Zhao and colleagues describe a standardized whole-blood stimulation protocol for testing how metabolic interventions alter human immune-cell cytokine responses. Its central contribution is a practical framework for combining immune challenges, metabolic modulation, and cytokine measurement in a physiologically complex sample, while highlighting the need to separate pathway-specific effects from donor and stimulus variability.
-
1,2-Dioleoyl-sn-glycero-3-PE (DOPE) Guide
2026-09-24
DOPE is a helper phospholipid for researchers formulating cationic liposomes and other lipid systems for nucleic acid delivery; it is supplied as a water-insoluble solid that requires suitable organic-solvent handling. Use it as a formulation component to evaluate, not as a standalone aqueous reagent or a guaranteed transfection enhancer, and validate composition and performance in the intended assay.
-
DOTAP: From Transfection Reagent to Assay Design
2026-09-24
DOTAP is a versatile cationic lipid for nucleic acid delivery, but its performance depends on formulation and biological context. This guide connects its practical use in transfection workflows with lessons from self-amplifying RNA research—and clarifies what that cardiac study does and does not show about DOTAP.
-
BOP Reagent for Peptide and Prodrug Workflows
2026-09-23
BOP reagent enables controlled carboxyl group activation for amide bond formation, phenyl ester preparation, and linker synthesis. This workflow connects practical solution-phase chemistry with the carrier-free, ROS-responsive prodrug strategy reported for targeted oral squamous cell carcinoma research.
-
7-AAD Cell Viability Assay Kit for CAR-T Studies
2026-09-22
The 7-AAD Cell Viability Assay Kit provides a practical membrane-integrity endpoint for separating viable cells from necrotic and late-apoptotic populations in CAR-T experiments. Its red-shifted, relatively narrow emission profile supports multiplex panels with Annexin V, Calcein AM, FITC, PE, or APC while helping investigators track target-cell killing and effector-cell fratricide.
-
Berberine, RXRα/PPARγ, and SASP in Atherosclerosis
2026-09-22
The reference study identifies an RXRα/PPARγ/NEDD4 pathway through which berberine suppresses senescence-associated secretory phenotype inflammation in macrophage-derived foam cells and atherosclerotic plaques. Its combination of mouse disease modeling, foam-cell assays, Smart-seq analysis, and macrophage-specific RXRα knockdown provides a mechanistic framework for testing how nuclear-receptor signaling controls inflammatory aging.
-
Plk1 Control of Mitotic Checkpoint Disassembly
2026-09-21
Kaisaria and colleagues identify Polo-like kinase 1 as a direct regulator of p31comet, linking mitotic kinase activity to the timing of mitotic checkpoint complex disassembly. Their biochemical and cell-extract experiments show that Plk1 phosphorylation of p31comet at S102 suppresses its TRIP13-dependent activity, helping prevent premature checkpoint inactivation.
-
Light-Inducible RNA Release for Regulated Gene Therapy
2026-09-21
The reference study introduces a rationally designed light-inducible RNA-releasing protein (LIRP) that controls mammalian gene expression at the level of translational initiation. By combining compact allosteric regulation with AAV and cell-based delivery strategies, the work demonstrates externally tunable therapeutic activity in metabolic and retinal disease models while highlighting the remaining barriers to clinical translation.
-
M344 Histone Deacetylase Inhibitor Workflows
2026-09-20
M344 is a cell-permeable histone deacetylase inhibitor for connecting chromatin remodeling with proliferation, differentiation, apoptosis, migration, and treatment-response assays. This workflow translates evidence from neuroblastoma models into practical dose selection, assay design, troubleshooting, and combination-study strategies.
-
Berberine, RXRα/PPARγ, and SASP Inflammation
2026-09-19
A 2025 study identifies an RXRα/PPARγ/NEDD4 axis through which berberine suppresses SASP-associated inflammation in macrophage-derived foam cells and atherosclerotic plaques. Its combination of mouse disease modeling, Smart-seq transcriptomics, protein-mechanism assays, and macrophage-targeted RXRα knockdown provides a useful framework for testing PPARγ-dependent regulation of vascular senescence.
-
Podophyllotoxin: Mechanism and Research Workflow
2026-09-19
Podophyllotoxin is a plant-derived microtubule inhibitor used to study mitotic disruption, cell cycle arrest, and apoptosis. This guide separates the N1790 parent compound from Condyline formulations and from mechanistically distinct podophyllotoxin derivative 5p.
-
T0070907: A Practical PPARγ Antagonist Workflow
2026-09-18
T0070907 combines nanomolar PPARγ antagonism with a covalent binding mechanism, making it useful for separating receptor-dependent transcription from downstream cellular effects. This guide translates that profile into workflows for adipogenesis, macrophage inflammation, and cancer cell-cycle studies, with practical controls and troubleshooting steps.
-
Polyethylenimine Linear: PEI MW 40,000 Workflow
2026-09-17
Build a reproducible PEI transfection workflow for HEK-293 cells, transient gene expression, and recombinant protein production. This guide combines practical ratio optimization with a calcium-phosphate study’s key lesson: DNA concentration and total complex volume must be controlled together.
-
Luminescent ATP Detection Assay Kit Workflow
2026-09-17
Measure ATP across cultured cells, solutions, and tissue lysates with a sensitive firefly luciferase ATP assay that avoids harsh acid extraction. The workflow connects cellular ATP quantification with mitochondrial stress studies while preserving lysates for protein-based follow-up.
-
740 Y-P: PI 3-Kinase Activator Workflows
2026-09-17
Use 740 Y-P as a cell-permeable positive perturbation to connect PI3K/AKT signaling with vesicular trafficking, neuronal cell survival, and cancer-cell phenotypes. This workflow-focused guide covers dosing, controls, assay selection, and troubleshooting for reproducible in vitro experiments.